- JP-listed companies
- J-Pharma Co.,Ltd.
- Balance sheet
J-Pharma Co.,Ltd.【JP:520A】Balance sheet
Market cap
P/E ratio
J-Pharma develops innovative small-molecule drugs targeting LAT1 transporters to treat cancer and autoimmune diseases with novel mechanisms of action.
| 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 1,073 | 2,302 |
| Total cash & short-term investments | - | 1,073 | 2,302 |
| Total current assets | - | 1,190 | 2,839 |
| Total non-current assets | - | 18 | 18 |
| Total assets | - | 1,207 | 2,857 |
| Total current liabilities | - | 200 | 452 |
| Total non-current liabilities | - | 58 | 27 |
| Total liabilities | - | 257 | 479 |
| Retained earnings | - | -1,652 | -1,499 |
| Stockholders' equity | 1,408 | 950 | 2,378 |